Bradley Kroenig - 02 Aug 2023 Form 3 Insider Report for MIRA PHARMACEUTICALS, INC. (MIRA)

Role
Director
Signature
/s/ Michelle Yanez, Attorney-in-Fact for Bradley Kroenig
Issuer symbol
MIRA
Transactions as of
02 Aug 2023
Net transactions value
$0
Form type
3
Filing time
02 Aug 2023, 17:58:23 UTC
Next filing
08 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding MIRA Common Stock 50,000 02 Aug 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding MIRA Stock Option (right to buy) 02 Aug 2023 Common Stock 30,000 $5.00 Direct F1
holding MIRA Stock Option (right to buy) 02 Aug 2023 Common Stock 10,000 $5.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vested and became exercisable as to 23,334 shares on June 15, 2022 and 3,333 shares on June 15, 2023. 3,333 shares will become exercisable on June 15, 2024.
F2 The option vested and became exercisable in full on April 28, 2023.